Sean Smith
Analyst · Needham
Thanks, Peter and good morning, everyone. I’ll provide a brief analysis of our financial results for the second quarter of fiscal year 2015, we review our operating results, balance sheet, cash flows and our forecast going forward. Please turn to slide five, six and seven which show our sequentially quarterly IC and FPD revenue performance. As Peter stated, second quarter revenue was approximately $127.3 million at the high-end of our range, guided range. Revenues for IC photomask were $103.8 million up $2.3 million sequentially. As Peter mentioned, we saw solid demand for high-end memory mask as well as increased FPD sales during the quarter. Revenues for high-end IC photomask which ware 45-nanometers and below were $41.7 million or 40% of total sales, a new record for Photronics. Sequentially, high-end IC revenue was up $5.3 million or 15%, primarily related to increased high-end sales in the U.S. and in Korea. Mainstream IC sales during the quarter was $52.1 million, a sequential decline of $3 million primarily related to softness in the foundry mainstream logic sales in Asia. Revenues for FPD photomask were $23.5 million up 7% and $1.5 million sequentially. The increase was related to higher mainstream FPD orders that Peter alluded to. High-end FPD revenue for the quarter was $15 million which was down modestly for $400,000 on a sequential basis. Bracing Q2 sales out geographically, 67% of total sales were from Asia, 26% from North America and 7% from Europe. Now, let’s continue to the income statement. Gross margin for the second quarter was 26%, up 320 basis points sequentially. The increase was primarily related to the following items; one, increased volume, two, reduced variable costs primarily consumables and increased manufacturing efficiencies, three, reduced depreciation sequentially up $1.4 million and four, certainly manufacturing costs we allocate to R&D related call activity. Selling, general and administrative expenses for the second quarter increased by a modest $400,000 to $12.5 million. R&D expenses, which consists principally of continued development for our global advanced process technologies and qualifications at advanced nodes were $5.8 million up $1.1 million sequentially, due principally to increase leading edge foundry logic and FPD development costs. During the quarter, we generated operating income of $14.9 million or 11.7%. This represents an increase of 230 basis points from the first quarter that amounts to an 87% incremental margin on a sequential basis. Pad depreciation remains flat. The incremental margin would have been 51%. EBITDA, as defined in our credit agreement for the quarter was $34.8 million or $139 million on an annualized basis. Other expense net for the second quarter was $1.5 million, up sequentially by $200,000. During the second quarter, we recorded tax provision of $1.3 million, which includes the reduction of foreign tax NOL valuation allowance of $1.5 million that was no longer be needed. Excluding the valuation allowance adjustment, income tax expense would have been $2.8 million which was within our guided range. Minority interest expense was $2.1 million for the quarter and primarily relates to our partner share of PDMC’s profits for the second quarter. Minority interest expense decreased $1.1 million during the quarter. GAAP net income was $10.1 million or $0.14 per diluted share and includes $1.5 million or $0.02 per diluted share related to the reduction of the tax valuation allowance I previously discussed. At the end of the second quarter, we had 1,510 full-time employees, which equates to annualized revenue per employee of $337,000. Now turning to the balance sheet. Cash and cash equivalents at the end of the quarter amounted to $176 million. Our net cash, which is cash less debt, was $39 million at the end of the quarter, up $10 million sequentially. Working capital at the end of the quarter was $151 million as compared to $144 million at the end of Q1. Accounts receivable at the end of the quarter were $97.6 million down $1.6 million sequentially and other current assets were $24.7 million down $4.2 million sequentially, primarily as a result of reduced prepaid expenses. Accounts payable and accrued current liabilities at quarter end amounted to $153 million, down $14 million sequentially, primarily as a result of reduced accrued CapEx. At the end of the quarter, $56 million of CapEx was accrued for, which was down $10 million sequentially. Please turn to slide nine as we review our capitalization. Total debt at quarter end was $137 million. The principal components of outstanding debt includes $115 million 3.25% senior unsecured notes, 50% of which are due April 2016 and 50% which are due April, 2019 and approximately $22 million in capital lease obligations. Our leverage ratio improved to 1.01 times during the quarter. During the quarter and through today, we have not borrowed on our five-year $50 million credit agreement. Taking a look at cash flows, cash provided by operations for the second quarter 2015 was approximately $36 million. Depreciation and amortization was $19.5 million down approximately $1.4 million sequentially. Cash flow used in investing activities in Q2 2015 amounted to approximately $28 million, which is primarily all CapEx. And net cash used by financing activities during the quarter amounted to approximately $2 million. Please turn to slide 10 as we take a look ahead. By taking a look at CapEx, we expect our 2015 cash CapEx needs to be approximately $110 million. We do, however, have the flexibility to accelerate or decelerate our spend depending upon market conditions. And our 2015 investments were principally geared towards high-end leading edge products for IC and FPD applications, and we do expect to continue to generate free cash flow once again in 2015. Our visibility, as always, continues to be limited as our backlog is typically one to two weeks. We are projecting the revenue for the third quarter of 2015 to be in the range of $124 million to $133 million. We also expect our depreciation and amortization expense to increase this quarter to approximately $2 million to $2.7 million as additional tools come online. During 2015, our tax rate will be affected by the flow of income from jurisdictions for which we may have credits and upon our limited ability to recognize tax benefits in areas in which we are taxable. For the third quarter of 2015, this will equate to a range of $2 million to $3 million, and for fiscal 2015, we estimate total taxes will range from $9 million to $11 million. As a result, based upon our current operating model, we estimate earnings per share for the third quarter of 2015 to be in the range of $0.06 to $0.13 per diluted share. In summary, I’ll leave you with a few key thoughts. First, we expect top and bottom line improvement in 2015. Second, we expect our EBITDA continue to grow in 2015. Third, we’re confident about our business model and our ability to grow market share at the high end. We see continued opportunities in our customers’ businesses and node migration plans, and we have a strong financial position and excellent technology to capitalize on those plans. And finally, we expect to continue to build on the momentum that we have established over the past few years as a leader in advanced photomask technology. Now, I’d like to turn the call over to the operator for questions and answers.